Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data

Overview of attention for article published in BMC Medicine, October 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 11 X posts from 7 X users, with an upper bound of 20,986 followers.

RT @BMCMedicine: Using serious adverse events to assess trial representativeness. Read the interesting study by Peter Hanlon @PHanlon17…

18 Nov 2022

Reply Repost Favourite

New from #wellcometrust https://t.co/Df7nLeLGBA Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data.

01 Nov 2022

Reply Repost Favourite

New from #The_MRC https://t.co/Df7nLeLGBA Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data.

01 Nov 2022

Reply Repost Favourite

RT @FrancesMair: @PHanlon17 Trial participants experience less Serious adverse events (SAEs) than expected based on age/sex/condition hosp…

30 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.